Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus

MLA

Alejandra L. Tamez, et al. “Dapagliflozin as an Adjunct Therapy to Insulin in the Treatment of Patients with Type 1 Diabetes Mellitus.” Journal of Diabetes & Metabolic Disorders, vol. 14, Oct. 2015. EBSCOhost, https://doi.org/10.1186/s40200-015-0210-x.

APA

Alejandra L. Tamez, Lucas A. Garza, Hector E. Tamez, Mayra I. Hernandez, & Ana C. Polanco. (2015). Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus. Journal of Diabetes & Metabolic Disorders, 14. https://doi.org/10.1186/s40200-015-0210-x

Chicago

Alejandra L. Tamez, Lucas A. Garza, Hector E. Tamez, Mayra I. Hernandez, and Ana C. Polanco. 2015. “Dapagliflozin as an Adjunct Therapy to Insulin in the Treatment of Patients with Type 1 Diabetes Mellitus.” Journal of Diabetes & Metabolic Disorders 14 (October). doi:10.1186/s40200-015-0210-x.